What move does the options market price into Zai Lab's report?

Implied ±19.0%, either direction.

ZLABNasdaqManufacturing

Zai Lab Ltd (ZLAB) earnings date, market-implied expected move, and options open interest by expiry

22.09

+0.02 · +0.09%

post 21.69 −1.83%

Closed15:59 ET

Open21.78Volume637,839Mkt cap$2.5BEPS-0.18

Day21.63 – 21.8330%52-wk15.96 – 27.5050%

ZLAB

Zai Lab Ltd

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±19.0%implied · straddle

17.5425.79

spot 21.67exp Nov 20ATM strike 22.5ATM straddle 4.85IV 123%

Nov 2 close

Expected move

Inputs

Next report

Nov 5

before open · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

+13.66%

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

9hVRTX · supplierVertex posts Q3 revenue $3.44 billion, raises FY2026 guidance to $13.15 to $13.25 billion
15hGSK · supplierGSK total voting rights 4,045,439,182
4dBMY · supplierBristol Myers Squibb posts Q3 net earnings $2,162 million, diluted EPS $1.05, revenue $13,069 million

News

Largest filed tie

13F top-10 QoQ

+29.35%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

92 managers

Top fund weight

0.00%

ZLAB weight · VT

N-PORTJul 31 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Zai Lab (ZLAB) is expected to report on Nov 5 before open (estimated date).

Implied vs realized

8 reports

—≥ implied

Nov 12 '24Nov 12 '24confirmed—▼−6.85%—

Feb 27 '25Feb 27 '25confirmed—▼−1.97%—

May 8 '25May 8 '25confirmed—▲+2.75%—

Aug 7 '25Aug 7 '25confirmed—▼−11.98%—

Nov 6 '25Nov 6 '25confirmed—▼−6.65%—

Q1 FY26Feb 26 '26confirmed—▲+1.55%—

May 7 '26May 7 '26confirmed—▼−5.93%—

Q2 FY26Aug 6 '26confirmed—▲+13.66%—

quarterimplied−15%0+15%realized×

Q2 FY26—▲+13.66%—

May '26—▼−5.93%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 30 close

90.39OI · 4 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2,802+3%Nov 2017d310%

4,018+3%Dec 1845d5.08791+20%5.08

2,877+1%Jan 1573d0.763,7790%0.76

3,358+9%Mar 19136d4.038330%4.03

ExpiryPutsCallsP/C

Nov 2017d2,802+3%310%90.39

Dec 1845d4,018+3%791+20%5.08

Jan 1573d2,877+1%3,7790%0.76

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±19.0%

Funds 1

VT±0.0%

Suppliers 2

GSK±2.2%×0.12

PFE±2.0%×0.10

Dashed = straddle · × = co-movement · max 501dMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−47.81%as filednet margin · revenue +6.73% QoQ · −3.33% YoY

Revenue$106M+6.73%

Gross profit$58M54.70%−5.10%

Operating income−$76M−71.95%−10.24%

Pre-tax income−$52M−4.58%

Net income−$51M−47.81%+0.37%

Cost of revenue$48M+25.63%

Operating expenses$135M+3.04%

Tax−$1M−170.97%

Other income$25M+24.40%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 2 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

NFP ×1.32· ±3.5% vs ±2.7% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±3.5%3 of 10×1.32

PPIproducer prices±3.3%6 of 10×1.24

FOMCrate decision±2.5%10 of 24×0.93

CPROFcorporate profits±2.2%4 of 12×0.83

GDPgross domestic product±2.1%6 of 19×0.80

PCEpersonal income & outlays±1.9%6 of 19×0.70

CPIconsumer prices±1.9%3 of 10×0.69

Bar = avg |move| to ±4% · tick = ±2.7% avg day · ×base = |move| ÷ ±2.7% · min 6 releases

Earnings history

EPS -0.05 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.05	—
Q1 FY26	Feb 26 '26 · confirmed	-0.05	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod